Skip to Content

China Longyi Group International Holdings Ltd CGYG

Morningstar Rating
Unlock Our Analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

CGYG is trading at a 20% discount.
Price
$0.00
Fair Value
$5.76
Uncertainty
Extreme
1-Star Price
$5.48
5-Star Price
$9.29
Economic Moat
Mvlmxf
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if CGYG is a good fit for your portfolio.

Trading Information

Previous Close Price
Day Range
52-Week Range
Bid/Ask
/
Market Cap
Volume/Avg
/

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield
Dividend Yield (Forward)
Total Yield

Company Profile

China Longyi Group International Holdings Ltd is a holding company. Through its subsidiaries, it principally develops, manufactures and markets Superoxide Dismutase (SOD) products. SOD has applications in foods, drinks, skin care productions, pharmaceuticals, to combat ailments ranging from sunburn to rheumatoid arthritis. It produces and sells SOD Lifeblood which is a mixture of SOD and Enzymes as an antioxidant. The group primarily generates revenue from marketing its products in China.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Small Value
Total Number of Employees
47

Valuation

Metric
CGYG
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
CGYG

Financial Strength

Metric
CGYG
Quick Ratio
0.05
Current Ratio
0.27
Interest Coverage
−97.60
Quick Ratio
CGYG

Profitability

Metric
CGYG
Return on Assets (Normalized)
−48.31%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
CGYG

Biotechnology Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
NVO
Novo Nordisk A/S ADRQgbs$456.5 Bil
VRTX
Vertex Pharmaceuticals IncMzmch$91.4 Bil
REGN
Regeneron Pharmaceuticals IncWsjzdv$89.8 Bil
SGEN
Seagen Inc Ordinary SharesKxrktn$40.2 Bil
MRNA
Moderna IncVvkc$29.6 Bil
ARGX
argenx SE ADRXzgw$26.4 Bil
BNTX
BioNTech SE ADRZpl$23.9 Bil
ALNY
Alnylam Pharmaceuticals IncRplzth$21.1 Bil
BMRN
Biomarin Pharmaceutical IncVstwf$17.2 Bil
INCY
Incyte CorpKnyhdqt$12.2 Bil